In the contemporary landscape of women’s health, a new and complex phenomenon has emerged: the transformation of menopause from a natural biological transition into a high-stakes medical emergency. While increased awareness of women’s health is generally welcomed, experts are raising alarms that the narrative is being hijacked by commercial interests. This "meno-washing" of the midlife experience is not only leading to the over-medicalization of women’s bodies but is also obscuring the profound social and structural stressors that define the middle years.
Main Facts: The Rise of the ‘Hot Flush Gold Rush’
The current discourse surrounding menopause and its precursor, perimenopause, has shifted significantly. Sarah White, Chief Executive Officer of Jean Hailes for Women’s Health, has observed a troubling trend at her organization’s clinics: an influx of younger women, some in their early 30s, attributing a wide array of symptoms—from fatigue to anxiety—to perimenopause. While perimenopause can technically begin in one’s 30s, it typically does not manifest until the mid-40s.
The concern among clinicians is that by immediately labeling every discomfort as hormonal, the medical community and women themselves are overlooking other potential causes. This narrow focus is part of a broader "medicalization" of the female experience. Menopause is increasingly portrayed as a "devastating medical emergency" rather than a natural phase of life. This shift has created a lucrative market, often referred to as the "hot flush gold rush," where brands sell everything from "menopause chocolate" and "menopause tea" to "menopause-specific socks" at premium prices.
Furthermore, the clinical response to this transition has become increasingly pharmaceutical. Middle-aged women are now prescribed antidepressants at rates significantly higher than their male counterparts. In many cases, these drugs are used not just for mood stabilization but as off-label treatments for physiological symptoms like hot flashes, despite potential risks of dependency and withdrawal.
Chronology: From Taboo to Commercial Commodity
To understand the current state of menopause discourse, one must look at the evolution of how the transition has been framed over the last several decades.
- The Era of Silence: For much of the 20th century, menopause was a "silent" transition, rarely discussed in public and often dismissed by the male-dominated medical establishment. This lack of information left many women feeling isolated and unsupported.
- The Hormone Replacement Therapy (HRT) Boom and Bust: In the 1990s, HRT was marketed as a "fountain of youth." However, following the 2002 Women’s Health Initiative study, which highlighted potential risks, use plummeted, and menopause returned to the shadows of medical discourse.
- The Modern Resurgence: In the last five to ten years, menopause has broken into the mainstream media. High-profile celebrities and social media influencers have championed the cause of "menopause awareness."
- The Commercial Pivot: Recognizing a gap in the market, commercial entities began "meno-washing"—rebranding standard products as menopause-specific to appeal to middle-aged women, who often possess significant disposable income.
- The Digital Amplification: Today, social media algorithms prioritize high-emotion content. This has led to a saturation of "catastrophic" narratives—images of women fanning themselves in distress or suffering from "brain fog"—which reinforces the idea of menopause as a period of inevitable decline.
Supporting Data: The Statistics of Over-Medicalization
The data surrounding the medicalization of menopause reveals a stark disparity in how midlife distress is treated across genders.
The Symptom Expansion
According to Martha Hickey, Professor of Obstetrics and Gynaecology at the University of Melbourne, approximately 200 different symptoms are now commonly ascribed to menopause in popular media and commercial marketing. However, scientific research rigorously links only two primary symptoms to the hormonal transition: vaginal dryness and vasomotor symptoms (hot flashes and night sweats). The remaining 198 symptoms—ranging from joint pain to hair loss—may be related to aging, stress, or other lifestyle factors, yet they are frequently sold to women as "menopause-driven" issues.
Pharmaceutical Trends
The reliance on psychiatric medication for menopausal women is a growing concern. Research indicates:
- Antidepressant Use: In the United States, women are approximately 2.5 times more likely to use antidepressants than men. Use peaks specifically among women in their 40s and 50s.
- Diagnosis Disparity: Women over the age of 45 are nearly twice as likely to be diagnosed with an anxiety disorder and 1.5 times as likely to be diagnosed with a depressive disorder compared to men of the same age.
- Health Risks: Women of menopausal age are uniquely vulnerable to side effects associated with SSRIs and SNRIs, including an increased risk of bone fractures and cardiovascular events.
The Impact of Expectations
A pivotal 1995 study published in PubMed found that a woman’s expectations about menopause significantly predict the severity of her eventual symptoms. This suggests a "self-fulfilling prophecy" effect; the more a woman is conditioned by media to fear the transition, the more distress she is likely to experience when it arrives.
Official Responses: Advocacy vs. Industry Influence
The response from the medical and regulatory community is divided between those seeking to protect women from exploitation and those who, perhaps inadvertently, lean into the medicalized narrative.
Sarah White, who also serves on the Women’s Health Products Working Group for Australia’s Therapeutic Goods Administration (TGA), has been vocal about the need for better regulation. She compares the current menopause marketing tactics to those of the tobacco industry, noting that companies "hijack the narrative" to sell products rather than advocate for systemic change. White argues that the lack of consistent, high-quality research has left a "knowledge gap" that commercial interests are more than happy to fill with "crap."
Professor Martha Hickey emphasizes the need for a cultural shift in how we view the transition. She points out that the medical establishment has "done a disservice to women" by failing to provide a balanced view. Hickey advocates for the "normalization" of menopause, comparing it to pregnancy: a natural process that usually goes well but requires medical intervention only when specific complications arise.
Sociologists like Emine Öncüler Yayalar and marketing researchers like Ayse Öncüler have analyzed the language used by brands. They found that "empowerment" messaging often places the entire burden of health on the individual woman, requiring her to "optimize" her body through endless consumption, rather than questioning why the environment she lives in is so stressful.
Implications: The ‘Midlife Collision’ and the Need for Structural Change
The implications of the current menopause narrative extend far beyond the doctor’s office. By framing midlife distress as a purely hormonal issue, society ignores the "midlife collision"—the unique intersection of stressors that women face in their 40s and 50s.
The Structural Reality
Many women in this age bracket are members of the "sandwich generation," simultaneously caring for aging parents and dependent children. They also face gendered ageism in the workplace, where their experience is often undervalued, and financial pressures as they approach retirement. Research shows that Black women and women from marginalized backgrounds experience more frequent and severe vasomotor symptoms, suggesting that structural racism and socio-economic stress play a significant role in the physiological experience of menopause.
Workplace Consequences
The push for "menopause-friendly" workplace accreditations, while well-intentioned, may have unintended negative consequences. Sarah White warns that some training packages suggest women "fall off a productivity cliff" when they hit menopause. If employers internalize the idea that middle-aged women are inherently less productive due to their hormones, it could lead to increased bias and reduced career opportunities for a subpopulation that is, in reality, highly productive.
Cultural Alternatives
The Western "decline" narrative is not universal. In China, menopause is often referred to as the "Second Spring," a time of rebirth and liberation from the burdens of menstruation and contraception. Studies show that Chinese women often report fewer symptoms and lower distress. Similarly, in many Indigenous cultures, menopausal women are elevated to the status of respected elders. These cultural variations prove that the experience of menopause is as much a social construct as it is a biological one.
The Path Forward: Prepared, Not Scared
The consensus among experts like White and Hickey is not that menopause symptoms should be ignored, but that they should be contextualized. There is an urgent need for:
- Independent Education: Menopause resources that are free from pharmaceutical and commercial sponsorship.
- Cognitive Behavioral Therapy (CBT): Promoting non-drug interventions that help women manage the psychological distress and "catastrophizing" of symptoms.
- Structural Reform: Addressing the "midlife collision" through better social support for caregivers and more equitable workplace policies.
Ultimately, the goal is to reach a place where women can enter midlife "prepared, but not scared." As the "white pants" anecdote suggests, there are significant positives to the end of menstruation. By stripping away the commercial "meno-washing" and the pathologizing labels, society can begin to view menopause not as a disease to be cured, but as a natural, manageable, and even empowering transition into a new phase of life.
